Core Scientific, Inc. current report, 29 December 2021

SEC Filing Summary

Issuer: Power & Digital Infrastructure Acquisition Corp. (XPDI), which announced its planned business combination with Core Scientific Holding Co. The Form 8-K reports an agreement amendment dated December 29, 2021; the filing was signed December 30, 2021.

Business Context and Transaction

XPDI, a special purpose acquisition company, previously agreed to acquire Core Scientific through a series of mergers. Amendment No. 2 removes XPDI Merger Sub 2, LLC as a transaction party and changes the structure so that, after the first merger, Core Scientific will merge into XPDI, with XPDI continuing as the surviving entity.

The proposed transaction remained subject to applicable conditions, including stockholder approval and other closing requirements. Exhibit 2.1 contains the full amendment.

Financial Metrics and Liquidity

The filing does not provide current-period or prior-period revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics. It references projected financial information and the combined company’s expected cash position but does not present clear values in this filing.

Material Changes Versus Prior Disclosure

  • The transaction structure was amended to eliminate the second merger subsidiary.
  • Core Scientific is expected to merge into XPDI after completion of the first merger, rather than into XPDI Merger Sub 2.
  • No changes to financial results or operating performance are reported.

Outlook, Risks, and Unusual Items

The filing contains forward-looking statements regarding the transaction, potential enterprise value, revenue and performance projections, growth, access to clean and renewable energy, talent, cash resources, and expected transaction benefits. These statements are not guarantees and remain subject to substantial uncertainty.

  • Key transaction risks include failure to obtain stockholder or regulatory approvals, delays, unanticipated closing conditions, redemption requests, litigation, and failure to realize expected benefits.
  • Operating risks include digital-asset price volatility, changes in mining rewards, limited electricity availability, competition, cybersecurity threats, talent retention, and the ability to scale.
  • Additional risks include evolving blockchain and digital-asset regulation, environmental and tax-law changes, COVID-19 impacts, and uncertainty in projected financial information.

Important Facts to Verify

  • Whether XPDI stockholders approved the proposed transaction and whether all other closing conditions were satisfied.
  • The final merger structure, transaction completion date, and resulting corporate entity and ticker symbols.
  • Actual financing, cash proceeds, redemption levels, debt, and post-closing liquidity.
  • Core Scientific’s historical and projected revenue, profitability, cash flow, operating capacity, energy costs, and digital-asset exposure.
  • The assumptions and risks underlying the projected financial information and anticipated transaction benefits.